ZipHealth.co: Your Quick Guide to Pharmaceuticals - Page 6

Annual Savings from FDA Generic Drug Approvals: Year-by-Year Breakdown

Beata Staszkow
|
December 31
|
8

Year-by-year breakdown of how much the U.S. saves thanks to FDA-approved generic drugs, from $7.1 billion in 2019 to $445 billion in 2023 total savings. Learn how generics cut costs, who benefits, and why savings vary.

Monitoring During Immunosuppressive Therapy: Essential Lab Tests and Imaging for Safety and Effectiveness

Keith Ashcroft
|
December 29
|
13

Essential lab tests and imaging for patients on immunosuppressive therapy to prevent rejection, toxicity, and infection. Learn how drug levels, TTV monitoring, and routine blood work keep you safe long-term.

Migraine Combination Medications: Generic Options and How They Work

Beata Staszkow
|
December 28
|
9

Discover how generic migraine combination medications like sumatriptan/naproxen and acetaminophen/aspirin/caffeine offer better relief at a fraction of the cost. Learn which combos work best and how to use them safely.

PTSD Nightmares: How Prazosin and Sleep Therapies Actually Work

Keith Ashcroft
|
December 27
|
14

PTSD nightmares are more than bad dreams-they're a neurological symptom that disrupts recovery. Learn how prazosin, CBT-I, and imagery rehearsal therapy work, what the research says, and which approach is right for you.

Physical Therapy for Pain: Exercise, Stretching, and Restoration

Beata Staszkow
|
December 26
|
11

Physical therapy for pain uses exercise, stretching, and movement to reduce chronic and acute pain without drugs. Proven methods like tai chi, water aerobics, and daily micro-exercises help restore function and break pain cycles safely.

FDA Listing for Biosimilars: How They Are Evaluated and Approved

Keith Ashcroft
|
December 25
|
8

The FDA doesn't rate biosimilars like generics - it rigorously evaluates them for molecular similarity, safety, and efficacy. Learn how the approval process works, why only 17 are interchangeable, and how they're changing patient access to biologics.

SGLT2 Inhibitors and Bone Health: What You Need to Know About Fracture Risk

Beata Staszkow
|
December 24
|
8

SGLT2 inhibitors help manage diabetes and protect the heart and kidneys, but canagliflozin may increase fracture risk in vulnerable patients. Empagliflozin and dapagliflozin appear safe for bone health. Know which drug is right for you.

Antipsychotics and Cardiac Medications: Understanding QT Prolongation Risks

Beata Staszkow
|
December 20
|
12

Antipsychotics can save lives, but they carry a hidden cardiac risk: QT prolongation. Learn which drugs pose the greatest danger, how heart medications amplify the risk, and what steps you can take to stay safe without stopping treatment.

When to Recommend Authorized Generics: Pharmacist’s Practical Guide

Keith Ashcroft
|
December 19
|
9

Pharmacists should recommend authorized generics for patients with allergies, narrow therapeutic index drugs, or modified-release formulations. Learn when and why to suggest them over regular generics.

Regulatory Oversight of Online Pharmacies: How FDA and State Boards Protect You

Beata Staszkow
|
December 18
|
15

Learn how the FDA and state pharmacy boards work together to regulate online pharmacies, protect patients from counterfeit drugs, and enforce rules on telemedicine prescriptions in 2025.